Modeling patients' time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants

• 主要な著者: Aapeli Leminen (著者), Mikko Pyykönen (著者), Juho Tynkkynen (著者), Markku Tykkyläinen (著者), Tiina Laatikainen (著者)
• フォーマット: 図書
• 出版事項: BMC, 2019-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Anticoagulation therapy is used for atrial fibrillation (AF) patients for reducing the risk of cardioembolic complications such as stroke. The previously recommended anticoagulant, warfarin, has a narrow therapeutic window, and it requires regular laboratory monitoring, unlike di...